Table of Contents Feed for the Digital Edition of Drug Information Journal - July 2008 Drug Information Journal - July 2008 Contents Continuing Education: Coordination Data Monitoring Committess and Adaptive Clinical Trial Designs Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials Current Statistical Requirements for Phamaceutical Clinical Trials in China Adaptive Design and Decision Analysis - Companions for Transforming Clinical Development Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group Preparing Regulatory Submissions with the FDA Reviewer in Mind: Use of the Clinical Review Template and Clinical Safety Reviewer Guidance by Sponsors Evaluation of Some Alternative Designs for Phase 2 Mulitple Sclerosis Trials - A Simulation Study Introduction Regulatory Requirements and Informed Consent Consent Comprehension in the 21st Century: What Is Missing? Consent Forms, Lower Reading Levels, and Using Flesch-Kincaid Readability Software 2008 Annual Meeting Student Poster Abstracts African Regulatory Conference Drug Information Journal - July 2008 Drug Information Journal - July 2008 - (Page Intro) Drug Information Journal - July 2008 - Drug Information Journal - July 2008 (Page Cover1) Drug Information Journal - July 2008 - Drug Information Journal - July 2008 (Page Cover2) Drug Information Journal - July 2008 - Drug Information Journal - July 2008 (Page 287) Drug Information Journal - July 2008 - Drug Information Journal - July 2008 (Page 288) Drug Information Journal - July 2008 - Drug Information Journal - July 2008 (Page 289) Drug Information Journal - July 2008 - Drug Information Journal - July 2008 (Page 290) Drug Information Journal - July 2008 - Drug Information Journal - July 2008 (Page 291) Drug Information Journal - July 2008 - Drug Information Journal - July 2008 (Page 292) Drug Information Journal - July 2008 - Drug Information Journal - July 2008 (Page 293) Drug Information Journal - July 2008 - Drug Information Journal - July 2008 (Page 294) Drug Information Journal - July 2008 - Contents (Page 295) Drug Information Journal - July 2008 - Contents (Page 296) Drug Information Journal - July 2008 - Continuing Education: Coordination Data Monitoring Committess and Adaptive Clinical Trial Designs (Page 297) Drug Information Journal - July 2008 - Continuing Education: Coordination Data Monitoring Committess and Adaptive Clinical Trial Designs (Page 298) Drug Information Journal - July 2008 - Continuing Education: Coordination Data Monitoring Committess and Adaptive Clinical Trial Designs (Page 299) Drug Information Journal - July 2008 - Continuing Education: Coordination Data Monitoring Committess and Adaptive Clinical Trial Designs (Page 300) Drug Information Journal - July 2008 - Continuing Education: Coordination Data Monitoring Committess and Adaptive Clinical Trial Designs (Page 301) Drug Information Journal - July 2008 - Continuing Education: Coordination Data Monitoring Committess and Adaptive Clinical Trial Designs (Page 302) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 303) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 304) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 305) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 306) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 307) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 308) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 309) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 310) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 311) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 312) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 313) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 314) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 315) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 316) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 317) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 318) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 319) Drug Information Journal - July 2008 - Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials (Page 320) Drug Information Journal - July 2008 - Current Statistical Requirements for Phamaceutical Clinical Trials in China (Page 321) Drug Information Journal - July 2008 - Current Statistical Requirements for Phamaceutical Clinical Trials in China (Page 322) Drug Information Journal - July 2008 - Current Statistical Requirements for Phamaceutical Clinical Trials in China (Page 323) Drug Information Journal - July 2008 - Current Statistical Requirements for Phamaceutical Clinical Trials in China (Page 324) Drug Information Journal - July 2008 - Current Statistical Requirements for Phamaceutical Clinical Trials in China (Page 325) Drug Information Journal - July 2008 - Current Statistical Requirements for Phamaceutical Clinical Trials in China (Page 326) Drug Information Journal - July 2008 - Current Statistical Requirements for Phamaceutical Clinical Trials in China (Page 327) Drug Information Journal - July 2008 - Current Statistical Requirements for Phamaceutical Clinical Trials in China (Page 328) Drug Information Journal - July 2008 - Current Statistical Requirements for Phamaceutical Clinical Trials in China (Page 329) Drug Information Journal - July 2008 - Current Statistical Requirements for Phamaceutical Clinical Trials in China (Page 330) Drug Information Journal - July 2008 - Adaptive Design and Decision Analysis - Companions for Transforming Clinical Development (Page 331) Drug Information Journal - July 2008 - Adaptive Design and Decision Analysis - Companions for Transforming Clinical Development (Page 332) Drug Information Journal - July 2008 - Adaptive Design and Decision Analysis - Companions for Transforming Clinical Development (Page 333) Drug Information Journal - July 2008 - Adaptive Design and Decision Analysis - Companions for Transforming Clinical Development (Page 334) Drug Information Journal - July 2008 - Adaptive Design and Decision Analysis - Companions for Transforming Clinical Development (Page 335) Drug Information Journal - July 2008 - Adaptive Design and Decision Analysis - Companions for Transforming Clinical Development (Page 336) Drug Information Journal - July 2008 - Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 337) Drug Information Journal - July 2008 - Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 338) Drug Information Journal - July 2008 - Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 339) Drug Information Journal - July 2008 - Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 340) Drug Information Journal - July 2008 - Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 341) Drug Information Journal - July 2008 - Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 342) Drug Information Journal - July 2008 - Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 343) Drug Information Journal - July 2008 - Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 344) Drug Information Journal - July 2008 - Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 345) Drug Information Journal - July 2008 - Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 346) Drug Information Journal - July 2008 - Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 347) Drug Information Journal - July 2008 - Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 348) Drug Information Journal - July 2008 - Preparing Regulatory Submissions with the FDA Reviewer in Mind: Use of the Clinical Review Template and Clinical Safety Reviewer Guidance by Sponsors (Page 349) Drug Information Journal - July 2008 - Preparing Regulatory Submissions with the FDA Reviewer in Mind: Use of the Clinical Review Template and Clinical Safety Reviewer Guidance by Sponsors (Page 350) Drug Information Journal - July 2008 - Preparing Regulatory Submissions with the FDA Reviewer in Mind: Use of the Clinical Review Template and Clinical Safety Reviewer Guidance by Sponsors (Page 351) Drug Information Journal - July 2008 - Preparing Regulatory Submissions with the FDA Reviewer in Mind: Use of the Clinical Review Template and Clinical Safety Reviewer Guidance by Sponsors (Page 352) Drug Information Journal - July 2008 - Preparing Regulatory Submissions with the FDA Reviewer in Mind: Use of the Clinical Review Template and Clinical Safety Reviewer Guidance by Sponsors (Page 353) Drug Information Journal - July 2008 - Preparing Regulatory Submissions with the FDA Reviewer in Mind: Use of the Clinical Review Template and Clinical Safety Reviewer Guidance by Sponsors (Page 354) Drug Information Journal - July 2008 - Preparing Regulatory Submissions with the FDA Reviewer in Mind: Use of the Clinical Review Template and Clinical Safety Reviewer Guidance by Sponsors (Page 355) Drug Information Journal - July 2008 - Preparing Regulatory Submissions with the FDA Reviewer in Mind: Use of the Clinical Review Template and Clinical Safety Reviewer Guidance by Sponsors (Page 356) Drug Information Journal - July 2008 - Preparing Regulatory Submissions with the FDA Reviewer in Mind: Use of the Clinical Review Template and Clinical Safety Reviewer Guidance by Sponsors (Page 357) Drug Information Journal - July 2008 - Preparing Regulatory Submissions with the FDA Reviewer in Mind: Use of the Clinical Review Template and Clinical Safety Reviewer Guidance by Sponsors (Page 358) Drug Information Journal - July 2008 - Evaluation of Some Alternative Designs for Phase 2 Mulitple Sclerosis Trials - A Simulation Study (Page 359) Drug Information Journal - July 2008 - Evaluation of Some Alternative Designs for Phase 2 Mulitple Sclerosis Trials - A Simulation Study (Page 360) Drug Information Journal - July 2008 - Evaluation of Some Alternative Designs for Phase 2 Mulitple Sclerosis Trials - A Simulation Study (Page 361) Drug Information Journal - July 2008 - Evaluation of Some Alternative Designs for Phase 2 Mulitple Sclerosis Trials - A Simulation Study (Page 362) Drug Information Journal - July 2008 - Evaluation of Some Alternative Designs for Phase 2 Mulitple Sclerosis Trials - A Simulation Study (Page 363) Drug Information Journal - July 2008 - Evaluation of Some Alternative Designs for Phase 2 Mulitple Sclerosis Trials - A Simulation Study (Page 364) Drug Information Journal - July 2008 - Evaluation of Some Alternative Designs for Phase 2 Mulitple Sclerosis Trials - A Simulation Study (Page 365) Drug Information Journal - July 2008 - Evaluation of Some Alternative Designs for Phase 2 Mulitple Sclerosis Trials - A Simulation Study (Page 366) Drug Information Journal - July 2008 - Evaluation of Some Alternative Designs for Phase 2 Mulitple Sclerosis Trials - A Simulation Study (Page 367) Drug Information Journal - July 2008 - Evaluation of Some Alternative Designs for Phase 2 Mulitple Sclerosis Trials - A Simulation Study (Page 368) Drug Information Journal - July 2008 - Introduction (Page 369) Drug Information Journal - July 2008 - Introduction (Page 370) Drug Information Journal - July 2008 - Regulatory Requirements and Informed Consent (Page 371) Drug Information Journal - July 2008 - Regulatory Requirements and Informed Consent (Page 372) Drug Information Journal - July 2008 - Regulatory Requirements and Informed Consent (Page 373) Drug Information Journal - July 2008 - Regulatory Requirements and Informed Consent (Page 374) Drug Information Journal - July 2008 - Consent Comprehension in the 21st Century: What Is Missing? (Page 375) Drug Information Journal - July 2008 - Consent Comprehension in the 21st Century: What Is Missing? (Page 376) Drug Information Journal - July 2008 - Consent Comprehension in the 21st Century: What Is Missing? (Page 377) Drug Information Journal - July 2008 - Consent Comprehension in the 21st Century: What Is Missing? (Page 378) Drug Information Journal - July 2008 - Consent Comprehension in the 21st Century: What Is Missing? (Page 379) Drug Information Journal - July 2008 - Consent Comprehension in the 21st Century: What Is Missing? (Page 380) Drug Information Journal - July 2008 - Consent Comprehension in the 21st Century: What Is Missing? (Page 381) Drug Information Journal - July 2008 - Consent Comprehension in the 21st Century: What Is Missing? (Page 382) Drug Information Journal - July 2008 - Consent Comprehension in the 21st Century: What Is Missing? (Page 383) Drug Information Journal - July 2008 - Consent Comprehension in the 21st Century: What Is Missing? (Page 384) Drug Information Journal - July 2008 - Consent Forms, Lower Reading Levels, and Using Flesch-Kincaid Readability Software (Page 385) Drug Information Journal - July 2008 - Consent Forms, Lower Reading Levels, and Using Flesch-Kincaid Readability Software (Page 386) Drug Information Journal - July 2008 - Consent Forms, Lower Reading Levels, and Using Flesch-Kincaid Readability Software (Page 387) Drug Information Journal - July 2008 - Consent Forms, Lower Reading Levels, and Using Flesch-Kincaid Readability Software (Page 388) Drug Information Journal - July 2008 - Consent Forms, Lower Reading Levels, and Using Flesch-Kincaid Readability Software (Page 389) Drug Information Journal - July 2008 - Consent Forms, Lower Reading Levels, and Using Flesch-Kincaid Readability Software (Page 390) Drug Information Journal - July 2008 - Consent Forms, Lower Reading Levels, and Using Flesch-Kincaid Readability Software (Page 391) Drug Information Journal - July 2008 - Consent Forms, Lower Reading Levels, and Using Flesch-Kincaid Readability Software (Page 392) Drug Information Journal - July 2008 - Consent Forms, Lower Reading Levels, and Using Flesch-Kincaid Readability Software (Page 393) Drug Information Journal - July 2008 - Consent Forms, Lower Reading Levels, and Using Flesch-Kincaid Readability Software (Page 394) Drug Information Journal - July 2008 - 2008 Annual Meeting Student Poster Abstracts (Page 395) Drug Information Journal - July 2008 - 2008 Annual Meeting Student Poster Abstracts (Page 396) Drug Information Journal - July 2008 - 2008 Annual Meeting Student Poster Abstracts (Page 397) Drug Information Journal - July 2008 - 2008 Annual Meeting Student Poster Abstracts (Page 398) Drug Information Journal - July 2008 - 2008 Annual Meeting Student Poster Abstracts (Page 399) Drug Information Journal - July 2008 - 2008 Annual Meeting Student Poster Abstracts (Page 400) Drug Information Journal - July 2008 - African Regulatory Conference (Page 401) Drug Information Journal - July 2008 - African Regulatory Conference (Page 402) Drug Information Journal - July 2008 - African Regulatory Conference (Page 403) Drug Information Journal - July 2008 - African Regulatory Conference (Page 404) Drug Information Journal - July 2008 - African Regulatory Conference (Page 405) Drug Information Journal - July 2008 - African Regulatory Conference (Page 406) Drug Information Journal - July 2008 - African Regulatory Conference (Page 407) Drug Information Journal - July 2008 - African Regulatory Conference (Page 408) Drug Information Journal - July 2008 - African Regulatory Conference (Page 409) Drug Information Journal - July 2008 - African Regulatory Conference (Page 410) Drug Information Journal - July 2008 - African Regulatory Conference (Page Cover3) Drug Information Journal - July 2008 - African Regulatory Conference (Page Cover4)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.